8 results
Contraindications to Thrombolytics

#Thrombolysis #Diagnosis #Management #Contraindications #Thrombolytics #TPA #STEMI #Stroke #CVA #Absolute #Relative
Contraindications to Thrombolytics ... #Thrombolysis ... Contraindications #Thrombolytics ... #TPA #STEMI #Stroke ... #CVA #Absolute
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
History of Systemic Thrombolysis ... for Ischemic Stroke ... EBM #Neurology #Stroke ... #Thrombolytics ... #Controversy #CVA
Alteplase (t-PA) for Acute Ischemic Stroke: 
Dosage, Mixing, and Administration Instructions

#TPA #Thrombolytics #Stroke #CVA #Dosage #Dosing
Acute Ischemic Stroke ... Instructions #TPA #Thrombolytics ... #Stroke #CVA #Dosage ... #Instructions #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... loss (~2-3kg) • Empagliflozin ... Eric Strong @DrEricStrong ... - Strong Medicine ... SGLT2 #Inhibitors #Pharmacology
tPA Code Stroke Dosing Chart

Total Dose = 0.9 mg/kg (maximum dose =90 mg)
 - give 10%
tPA Code Stroke ... #Dosing #Dose #CVA ... #Thrombolytics ... #Stroke #Pharmacology
Atorvastatin. HMG-CoA reductase inhibitor (statin) for dyslipidemia and MI/stroke prevention. 2nd most prescribed drug in the
HMG-CoA reductase ... dyslipidemia and MI/stroke ... #Pharmacology #Atorvastatin
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Plateau Phase • Ca ... leading to slow Ca ... - CLASS 1C: Strong ... Antiarrhythmics #Pharmacology
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
- CLASS 1C: Strong ... receptors, and Ca ... MOA: Block slow Ca ... channels to prevent Ca ... Vaughan #Williams #Pharmacology